Cadrenal Therapeutics, Inc. Common Stock (CVKD) Revenue History
Annual and quarterly revenue from 2022 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CVKD Revenue Growth
CVKD Revenue Analysis (2022–2025)
As of May 8, 2026, Cadrenal Therapeutics, Inc. Common Stock (CVKD) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, CVKD's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including PTGX (-91.5% YoY), TCRX (+84.4% YoY), and NKTR (-43.9% YoY). Compare CVKD vs PTGX →
CVKD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CVKDCurrent | $0 | - | - | - | |
 PTGX | $46M | -91.5% | +10.0% | -343.6% | |
 TCRX | $10M | +84.4% | +56.9% | -1315.4% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 ARDX | $407M | +18.2% | +121.9% | -10.1% | |
 BMRN | $3.2B | +9.9% | +11.6% | 16.6% |
CVKD Historical Revenue Data (2022–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-13,461,177 | - |
| 2024 | $0 | - | $0 | - | $-10,960,619 | - |
| 2023 | $0 | - | $0 | - | $-7,632,843 | - |
| 2022 | $0 | - | $-1,266 | - | $-2,701,630 | - |
See CVKD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CVKD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CVKD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCVKD — Frequently Asked Questions
Quick answers to the most common questions about buying CVKD stock.
Is CVKD's revenue growth accelerating or slowing?
CVKD TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CVKD's long-term revenue growth rate?
Cadrenal Therapeutics, Inc. Common Stock's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CVKD's revenue distributed by segment?
CVKD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2025 are available for download. Segment mix reveals concentration and diversification trends.